Successful use of boric acid to control azole-refractory Candida vaginitis in a woman with AIDS.
Shinohara
Y T
YT
Tasker
S A
SA
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000282:Administration, Intravaginal; D000328:Adult; D000935:Antifungal Agents / Q000627:therapeutic use; D001888:Boric Acids / Q000627:therapeutic use*; D002181:Candidiasis, Vulvovaginal / Q000209:etiology / Q000517:prevention & control*; D004352:Drug Resistance, Microbial; D005260:Female; D015725:Fluconazole / Q000627:therapeutic use; D006801:Humans; D013488:Suppositories
D000935:Antifungal Agents; D001888:Boric Acids; D013488:Suppositories; D015725:Fluconazole; C032688:boric acid